SCHOTT PHARMA AG & CO. KGAA financial statements, including revenue, expenses, profit, and loss

The total revenue of 1SXP for the last quarter is 237.05 M EUR, and it's 6.52% lower compared to the previous quarter. The net income of Q4 24 is 33.97 M EUR.